POSA399 Treatment Pattern, Mortality and Costs Among BCG-Treated Non-Muscle Invasive Bladder Cancer (NMIBC) Patients in Germany

Abstract

Authors

N Quignot I Doobaree H Jiang J Lehmann O Ghatnekar

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×